Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Other(4)

Detailed Status

unknown4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown4100%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

PBMC Collection for Production of UCAR T Cells

NCT04963959
unknownnot_applicable

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

NCT04295096
unknownnot_applicable

Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study

NCT04448509
unknownnot_applicable

PBMC Donation in UCAR-T Cells

NCT04091906

Clinical Trials (4)

Showing 4 of 4 trials
NCT04963959Not Applicable

PBMC Collection for Production of UCAR T Cells

Unknown
NCT04295096Not Applicable

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

Unknown
NCT04448509Not Applicable

Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study

Unknown
NCT04091906Not Applicable

PBMC Donation in UCAR-T Cells

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4